ACRS
Aclaris Therapeutics Inc
NASDAQ: ACRS · HEALTHCARE · BIOTECHNOLOGY
$4.47
+5.92% today
Updated 2026-04-29
Market cap
$624.30M
P/E ratio
—
P/S ratio
79.77x
EPS (TTM)
$-0.53
Dividend yield
—
52W range
$1 – $5
Volume
2.0M
Aclaris Therapeutics Inc (ACRS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+16.7%
Last 4 quarters
Revenue YoY growth
-85.9%
Most recent quarter
EPS YoY growth
+84.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+2.1%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+2.7%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-03 | $-0.16 | -6.7% | $3.05 | $3.10 | +1.6% |
| 2025-11-06 | $-0.12 | +7.7% | $2.26 | $2.32 | +2.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.15 | $-0.16 | -6.7% | $1.29M | -85.9% |
| 2025-09-30 | $-0.13 | $-0.12 | +7.7% | $3.30M | -24.1% |
| 2025-06-30 | $-0.14 | $-0.13 | +7.1% | $1.78M | -35.8% |
| 2025-03-31 | $-0.29 | $-0.12 | +58.6% | $1.46M | -39.3% |
| 2024-12-31 | $-0.38 | $-1.01 | -169.3% | $9.21M | -47.6% |
| 2024-09-30 | $-0.01 | $-0.11 | -1000.0% | $4.35M | -53.2% |
| 2024-06-30 | $-0.20 | $-0.15 | +25.0% | $2.77M | +48.0% |
| 2024-03-31 | $-0.29 | $-0.24 | +17.2% | $2.40M | -5.1% |
| 2023-12-31 | $-0.34 | $-0.02 | +94.1% | $17.57M | — |
| 2023-09-30 | $-0.48 | $-0.41 | +14.6% | $9.28M | — |
| 2023-06-30 | $-0.45 | $-0.42 | +6.7% | $1.87M | — |
| 2023-03-31 | $-0.44 | $-0.40 | +9.1% | $2.53M | — |
Frequently asked questions
Has Aclaris Therapeutics Inc beaten earnings estimates?
Aclaris Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +16.7% over the last 4 quarters.
How does ACRS stock react to earnings?
ACRS stock has moved an average of +2.1% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Aclaris Therapeutics Inc's revenue growth rate?
Aclaris Therapeutics Inc reported year-over-year revenue growth of -85.9% in its most recent quarter, with EPS growing +84.2% year-over-year.